At the EnVision Summit 2025 in San Juan, Puerto Rico, Tania Tai, Lucy Shen, and Shivani Kamat all gave insight into ...

Zervimesine is an investigational oral, once-daily pill being developed for the treatment of CNS diseases, including ...

Researchers conducted a first-of-a-kind cross-sectional study at the outpatient clinic of the Eye Hospital of China Academy ...

The aim of the study was to assess the effect of a modified TCLB procedure that added deframing and decompression maneuvers ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

The research analyzed the 1-year outcomes of 132 eyes, evaluating mean IOP, baseline changes, medication reduction, and ...

Emerging technologies, such as remote tonometry and genetic risk scoring, are revolutionizing glaucoma care by enabling ...

Meibomian glands are critical to the ocular health in that they secrete lipid-rich meibum, which protects the ocular surface ...

Radhakrishnan noted that the awareness of dry eye in glaucoma patients had been increasing, and the availability of more ...

Outlook Therapeutics has re-submitted its Biologics License Application (BLA) to the US Food and Drug Administration (FDA) ...

Perceive Pharma raised $15M in Series A funding to develop neuroprotective therapeutics for glaucoma and other conditions.

At the Envision Summit 2025 in San Juan, Puerto Rico, Sara Wester, MD, discussed the Women Leaders in Eye Health session at ...